Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microfluidic Device Created For Genetic Analysis

By LabMedica International staff writers
Posted on 17 Aug 2011
A silicone chip based apparatus has been generated that could make genetic analysis far more sensitive, rapid, and cost-effective. More...


The device, which is about the size of a nine-volt battery, allows simultaneously analysis of 300 individual cells by routing fluid carrying cells through microscopic tubes and valves.

Scientists at the University of British Columbia, (UBC; Vancouver, BC, Canada) isolated the cells into their separate chambers, and then extracted and replicated the cells' ribonucleic acid (RNA) for further analysis. The device's ease of use and cost-effectiveness arise from its integration of almost the entire process of cell analysis, not just separating the cells, but also mixing them with chemical reagents to highlight their genetic code and analyzing the results by measuring fluorescent light emitted from the reaction. All of that can now be done on the chip.

The fully integrated microfluidic device is capable of performing high-precision real-time quantitative polymerase chain reaction (RT-qPCR) measurements of gene expression from hundreds of single cells per run. The device executes all steps of single-cell processing, including cell capture, cell lysis, reverse transcription, and quantitative PCR. By enabling such "single-cell analysis," the device could accelerate genetic research and hasten the use of far more detailed tests for diagnosing cancer. The standard genetic tests, which require large numbers of cells, capture only an average composite picture of thousands or millions of different cells that may obscure their true nature and the interactions between them.

Carl Hansen, PhD, an assistant professor at UCB said, "This technology and other approaches like it could radically change the way we do both basic and applied biomedical research, and would make single-cell analysis a more plausible option for treating patients, allowing clinicians to distinguish various cancers from one another and tailor their treatments accordingly." The study was published August 1, 2011, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

University of British Columbia




Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.